Commercialization FP&A Director
US$244,000 – US$305,000 / yr base salary
Posted 7 Oct 2026
Advertised as “Senior Director, Commercialization FP&A”
BranchFactor Summary
The original posting with the fluff stripped out
- Expected experience
- 12+ yrs
- Management level
- People management
- Employment
- Remote
| Base salary | US$244,000 – US$305,000 / yr |
|---|
Field of studyAccounting, Finance (or related)
Study levelBachelor's
CertificationsCertified Public Accountant, Master of Business Administration
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Revolution Medicines is seeking a Senior Director of Commercialization FP&A to join our growing Finance team. The Senior Director of Commercialization FP&A will act as the key financial business partner for our growing Global Commercialization organization and support Global Commercial & Access, Global Medical Affairs, and US Commercial teams. This role reports to the VP, FP&A.
Responsibilities include:
-
Build and maintain strong cross-functional business partnerships to forecast and track activities by embedding finance into decision-making processes.
-
Collaborate with various levels of management to gather, analyze, summarize, and prepare operating budgets and financial forecasts during planning cycles (e.g., annual budget, mid-year re-forecast, launch planning, etc.).
-
Provide financial direction to key stakeholders with influence with proactive recommendations, supported by robust financial analysis and insightful delivery.
-
Develop and prepare monthly internal financial management reporting packages and commercialization profit/loss reports for the global and US organizations, closely working with ex-US Finance colleagues to streamline overall approach and business rules across different regions.
-
Oversee monthly variance analysis of actuals to budget, investigate any major discrepancies, and articulate key business drivers.
-
Support ad hoc analyses and special projects, providing timely and accurate financial insights to support successful commercialization of medicines upon regulatory approval.
-
Help drive process improvements and efficiencies in areas of financial planning, financial analysis, and production of reporting packages.
Required Skills, Experience and Education: